Nonbioequivalent prescription drug interchangeability, concerns on patient safety and drug market dynamics in Brazil
Abstract Since the enforcement of Generics Act (1999), three types of pharmaceutically equivalent products are marketed in Brazil: innovative reference (REF), “similar” (S) and generic (G) drugs. The S (brand name) and G (generic name) borrow from REF (brand name) clinical data on safety and efficac...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Associação Brasileira de Pós-Graduação em Saúde Coletiva
|
| Series: | Ciência & Saúde Coletiva |
| Subjects: | |
| Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-81232017002802549&lng=en&tlng=en |